MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
953.35%
Quick Ratio
953.35%
Cash Ratio
170.70%
Debt to Asset Ratio
24.06%
Unit: Thousand (K) dollars
Assets Breakdown
Long-term investments
Short-term investments
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Long term debt
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
62,431
61,299
50,811
44,242
Short-term investments
214,158
233,281
195,403
206,482
Tax incentive receivable
56,431
53,917
49,121
40,704
Prepaid expenses and other current assets
15,659
19,378
12,340
8,935
Total current assets
348,679
367,875
307,675
300,363
Long-term investments
257,117
282,548
102,825
153,406
Property and equipment, net
722
807
894
733
Operating lease right-of-use assets
9,794
10,047
10,295
10,539
Deferred tax asset
24,171
24,778
25,022
25,366
Other non-current assets
1,280
1,440
1,589
1,720
Total assets
641,763
687,495
448,300
492,127
Accounts payable
10,658
7,582
8,683
5,692
Accrued expenses and other current liabilities
25,916
35,353
20,439
24,002
Total current liabilities
36,574
42,935
29,122
29,694
Long term debt
110,440
110,095
109,816
109,545
Operating lease liabilities
7,372
7,573
7,759
7,940
Other liabilities
29
29
29
29
Total liabilities
154,415
160,632
146,726
147,208
Ordinary shares 0.002 nominal value222,480,776shares authorized, 154,728,966 issued and outstanding at march31, 2026 222,480,776 shares authorized, 149,228,068 issued and outstanding at december31, 2025
419
405
364
363
Additional paid-in capital
1,750,996
1,709,978
1,418,681
1,408,145
Accumulated other comprehensive income
1,408
2,714
2,600
1,591
Accumulated deficit
-1,265,475
-1,186,234
-1,120,071
-1,065,180
Total shareholders equity
487,348
526,863
301,574
344,919
Total liabilities and shareholders' equity
641,763
687,495
448,300
492,127
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Short-term investments
$214,158K
(19.41%↑ Y/Y)
Cash and cash
equivalents
$62,431K
(-40.63%↓ Y/Y)
Tax incentive
receivable
$56,431K
(13.75%↑ Y/Y)
Prepaid expenses and
other current assets
$15,659K
(15.10%↑ Y/Y)
Total current assets
$348,679K
(0.28%↑ Y/Y)
Long-term investments
$257,117K
(83.14%↑ Y/Y)
Deferred tax asset
$24,171K
(-8.41%↓ Y/Y)
Operating lease
right-of-use assets
$9,794K
(-9.13%↓ Y/Y)
Other non-current
assets
$1,280K
(-31.99%↓ Y/Y)
Property and equipment,
net
$722K
(6.02%↑ Y/Y)
Total assets
$641,763K
(21.58%↑ Y/Y)
Total liabilities and
shareholders' equity
$641,763K
(21.58%↑ Y/Y)
Total shareholders
equity
$487,348K
(26.18%↑ Y/Y)
Total liabilities
$154,415K
(9.05%↑ Y/Y)
Accumulated deficit
-$1,265,475K
(-24.70%↓ Y/Y)
Additional paid-in capital
$1,750,996K
(25.19%↑ Y/Y)
Long term debt
$110,440K
(1.09%↑ Y/Y)
Total current
liabilities
$36,574K
(51.12%↑ Y/Y)
Operating lease
liabilities
$7,372K
(-9.16%↓ Y/Y)
Other liabilities
$29K
(0.00%↑ Y/Y)
Accumulated other
comprehensive income
$1,408K
(-32.14%↓ Y/Y)
Ordinary shares 0.002
nominal...
$419K
(15.75%↑ Y/Y)
Accrued expenses and
other current...
$25,916K
(35.90%↑ Y/Y)
Accounts payable
$10,658K
(107.68%↑ Y/Y)
Buy us a coffee
Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc (CNTA)